SC-26196 is a potent, orally active Delta6 desaturase (D6D, FADS2) inhibitor (IC50=0.2 µM in a rat liver microsomal assay). Antiinflammatory properties.
Application:
SC-26196 has been used as an inhibitor of delta6 (Δ6) fatty acid desaturase:
in mouse inner medullary collecting duct (IMCD3) and human (female) embryonic kidney (HEK) 293 cell culture as Dulbecco′s modified eagle′s medium (DMEM) component
in hepatic HepG2 cells
in glioblastoma cell lines to test its effect post-radiation treatments
选择性Δ6去饱和酶抑制剂(体外IC 50 = 0.2μM)。它显示出对Δ5和Δ9去饱和酶的选择性(体外IC 50值> 200μM)。在小鼠水肿模型中具有抗发炎特性。从卵巢癌细胞中消除CSC。SC-26196 is a Delta6 fatty acid desaturase (Delta6D) inhibitor. It specifically inhibited Delta6D activity with an IC(50) value of 100 nM. The rate-limiting step in arachidonic acid synthesis is the desaturation of dietary linoleic acid by Delta6D. SC-26196 completely prevented this conversion of linoleic acid to arachidonic acid.